Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-11

Clinical Trial Update: Escalating Monthly Doses of Tafenoquine in Healthy Volunteers [Phase 4]

View source ↗

Summary

Clinical trial update exploring escalating monthly doses of tafenoquine in healthy volunteers (Phase 4) for prophylaxis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tafenoquine (tafenoquine)

Snippet

Sponsor: Naval Medical Research Center | Conditions: Prophylaxis | Phase 4 | Status: UNKNOWN